#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat|salience|identity
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=Description :
1-1	0-11	Description	abstract[1]	new[1]	nonsal[1]	_	_	_	
1-2	12-13	:	_	_	_	_	_	_	

#Text=Posttransplant lymphoproliferative disorder , chronic renal insufficiency , squamous cell carcinoma of the skin , anemia secondary to chronic renal insufficiency and chemotherapy , and hypertension .
2-1	14-28	Posttransplant	abstract[2]	new[2]	sal[2]	_	coref	7-2[21_2]	
2-2	29-48	lymphoproliferative	abstract[2]	new[2]	sal[2]	_	_	_	
2-3	49-57	disorder	abstract[2]	new[2]	sal[2]	_	_	_	
2-4	58-59	,	_	_	_	_	_	_	
2-5	60-67	chronic	abstract[3]	new[3]	sal[3]	_	coref	2-19[9_3]	
2-6	68-73	renal	abstract[3]|object[4]	new[3]|new[4]	sal[3]|sal[4]	_	coref	2-20[10_4]	
2-7	74-87	insufficiency	abstract[3]	new[3]	sal[3]	_	_	_	
2-8	88-89	,	_	_	_	_	_	_	
2-9	90-98	squamous	abstract[5]|animal[6]	new[5]|new[6]	sal[5]|sal[6]	_	coref|coref	9-2[24_5]|9-2[25_6]	
2-10	99-103	cell	abstract[5]|animal[6]	new[5]|new[6]	sal[5]|sal[6]	_	_	_	
2-11	104-113	carcinoma	abstract[5]	new[5]	sal[5]	_	_	_	
2-12	114-116	of	abstract[5]	new[5]	sal[5]	_	_	_	
2-13	117-120	the	abstract[5]|object[7]	new[5]|new[7]	sal[5]|sal[7]	_	coref	9-6[26_7]	
2-14	121-125	skin	abstract[5]|object[7]	new[5]|new[7]	sal[5]|sal[7]	_	_	_	
2-15	126-127	,	_	_	_	_	_	_	
2-16	128-134	anemia	abstract[8]	new[8]	sal[8]	_	coref	10-2[27_8]	
2-17	135-144	secondary	abstract[8]	new[8]	sal[8]	_	_	_	
2-18	145-147	to	abstract[8]	new[8]	sal[8]	_	_	_	
2-19	148-155	chronic	abstract[8]|abstract[9]	new[8]|giv[9]	sal[8]|nonsal[9]	_	coref	8-2[22_9]	
2-20	156-161	renal	abstract[8]|abstract[9]|object[10]	new[8]|giv[9]|giv[10]	sal[8]|nonsal[9]|nonsal[10]	_	coref	10-6[29_10]	
2-21	162-175	insufficiency	abstract[8]|abstract[9]	new[8]|giv[9]	sal[8]|nonsal[9]	_	_	_	
2-22	176-179	and	abstract[8]	new[8]	sal[8]	_	_	_	
2-23	180-192	chemotherapy	abstract[8]|event[11]	new[8]|new[11]	sal[8]|sal[11]	_	coref	3-9[15_11]	
2-24	193-194	,	_	_	_	_	_	_	
2-25	195-198	and	_	_	_	_	_	_	
2-26	199-211	hypertension	abstract[12]	new[12]	sal[12]	_	coref	11-2[31_12]	
2-27	212-213	.	_	_	_	_	_	_	

#Text=The patient is here for followup visit and chemotherapy .
3-1	214-217	The	person[13]	new[13]	sal[13]	_	coref	5-1[17_13]	
3-2	218-225	patient	person[13]	new[13]	sal[13]	_	_	_	
3-3	226-228	is	_	_	_	_	_	_	
3-4	229-233	here	_	_	_	_	_	_	
3-5	234-237	for	_	_	_	_	_	_	
3-6	238-246	followup	event[14]	new[14]	sal[14]	_	coref	5-6[18_14]	
3-7	247-252	visit	event[14]	new[14]	sal[14]	_	_	_	
3-8	253-256	and	_	_	_	_	_	_	
3-9	257-269	chemotherapy	event[15]	giv[15]	nonsal[15]	_	coref	5-9[19_15]	
3-10	270-271	.	_	_	_	_	_	_	

#Text=CHIEF COMPLAINT :
4-1	272-277	CHIEF	abstract[16]	new[16]	nonsal[16]	_	_	_	
4-2	278-287	COMPLAINT	abstract[16]	new[16]	nonsal[16]	_	_	_	
4-3	288-289	:	_	_	_	_	_	_	

#Text=The patient is here for followup visit and chemotherapy .
5-1	290-293	The	person[17]	giv[17]	nonsal[17]	_	coref	13-1[34_17]	
5-2	294-301	patient	person[17]	giv[17]	nonsal[17]	_	_	_	
5-3	302-304	is	_	_	_	_	_	_	
5-4	305-309	here	_	_	_	_	_	_	
5-5	310-313	for	_	_	_	_	_	_	
5-6	314-322	followup	event[18]	giv[18]	nonsal[18]	_	_	_	
5-7	323-328	visit	event[18]	giv[18]	nonsal[18]	_	_	_	
5-8	329-332	and	_	_	_	_	_	_	
5-9	333-345	chemotherapy	event[19]	giv[19]	nonsal[19]	_	coref	10-9[30_19]	
5-10	346-347	.	_	_	_	_	_	_	

#Text=DIAGNOSES :
6-1	348-357	DIAGNOSES	abstract[20]	new[20]	nonsal[20]	_	_	_	
6-2	358-359	:	_	_	_	_	_	_	

#Text=1. Posttransplant lymphoproliferative disorder .
7-1	360-362	1.	_	_	_	_	_	_	
7-2	363-377	Posttransplant	abstract[21]	giv[21]	nonsal[21]	_	coref	13-11[35_21]	
7-3	378-397	lymphoproliferative	abstract[21]	giv[21]	nonsal[21]	_	_	_	
7-4	398-406	disorder	abstract[21]	giv[21]	nonsal[21]	_	_	_	
7-5	407-408	.	_	_	_	_	_	_	

#Text=2. Chronic renal insufficiency .
8-1	409-411	2.	_	_	_	_	_	_	
8-2	412-419	Chronic	abstract[22]	giv[22]	nonsal[22]	_	coref	10-5[28_22]	
8-3	420-425	renal	abstract[22]	giv[22]	nonsal[22]	_	_	_	
8-4	426-439	insufficiency	abstract[22]	giv[22]	nonsal[22]	_	_	_	
8-5	440-441	.	_	_	_	_	_	_	

#Text=3. Squamous cell carcinoma of the skin .
9-1	442-444	3.	abstract[23]	new[23]	nonsal[23]	_	_	_	
9-2	445-453	Squamous	abstract[23]|abstract[24]|animal[25]	new[23]|giv[24]|giv[25]	nonsal[23]|nonsal[24]|nonsal[25]	_	coref|coref	23-10[87_24]|23-10[88_25]	
9-3	454-458	cell	abstract[23]|abstract[24]|animal[25]	new[23]|giv[24]|giv[25]	nonsal[23]|nonsal[24]|nonsal[25]	_	_	_	
9-4	459-468	carcinoma	abstract[23]|abstract[24]	new[23]|giv[24]	nonsal[23]|nonsal[24]	_	_	_	
9-5	469-471	of	abstract[23]|abstract[24]	new[23]|giv[24]	nonsal[23]|nonsal[24]	_	_	_	
9-6	472-475	the	abstract[23]|abstract[24]|object[26]	new[23]|giv[24]|new[26]	nonsal[23]|nonsal[24]|nonsal[26]	_	coref	23-14[90_26]	
9-7	476-480	skin	abstract[23]|abstract[24]|object[26]	new[23]|giv[24]|new[26]	nonsal[23]|nonsal[24]|nonsal[26]	_	_	_	
9-8	481-482	.	_	_	_	_	_	_	

#Text=4. Anemia secondary to chronic renal insufficiency and chemotherapy .
10-1	483-485	4.	_	_	_	_	_	_	
10-2	486-492	Anemia	abstract[27]	giv[27]	nonsal[27]	_	coref	50-2[189_27]	
10-3	493-502	secondary	abstract[27]	giv[27]	nonsal[27]	_	_	_	
10-4	503-505	to	abstract[27]	giv[27]	nonsal[27]	_	_	_	
10-5	506-513	chronic	abstract[27]|abstract[28]	giv[27]|giv[28]	nonsal[27]|nonsal[28]	_	coref	49-2[188_28]	
10-6	514-519	renal	abstract[27]|abstract[28]|object[29]	giv[27]|giv[28]|giv[29]	nonsal[27]|nonsal[28]|nonsal[29]	_	coref	16-7[50_29]	
10-7	520-533	insufficiency	abstract[27]|abstract[28]	giv[27]|giv[28]	nonsal[27]|nonsal[28]	_	_	_	
10-8	534-537	and	abstract[27]	giv[27]	nonsal[27]	_	_	_	
10-9	538-550	chemotherapy	abstract[27]|event[30]	giv[27]|giv[30]	nonsal[27]|nonsal[30]	_	coref	18-1[59_30]	
10-10	551-552	.	_	_	_	_	_	_	

#Text=5. Hypertension .
11-1	553-555	5.	_	_	_	_	_	_	
11-2	556-568	Hypertension	abstract[31]	giv[31]	nonsal[31]	_	coref	52-2[198_31]	
11-3	569-570	.	_	_	_	_	_	_	

#Text=HISTORY OF PRESENT ILLNESS :
12-1	571-578	HISTORY	abstract[32]	new[32]	nonsal[32]	_	_	_	
12-2	579-581	OF	abstract[32]	new[32]	nonsal[32]	_	_	_	
12-3	582-589	PRESENT	abstract[32]|abstract[33]	new[32]|new[33]	nonsal[32]|nonsal[33]	_	_	_	
12-4	590-597	ILLNESS	abstract[32]|abstract[33]	new[32]|new[33]	nonsal[32]|nonsal[33]	_	_	_	
12-5	598-599	:	_	_	_	_	_	_	

#Text=A 51 - year - old white male diagnosed with PTLD in latter half of 2007 .
13-1	600-601	A	person[34]	new[34]	nonsal[34]	_	coref	14-1[38_34]	
13-2	602-604	51	person[34]	new[34]	nonsal[34]	_	_	_	
13-3	605-606	-	person[34]	new[34]	nonsal[34]	_	_	_	
13-4	607-611	year	person[34]	new[34]	nonsal[34]	_	_	_	
13-5	612-613	-	person[34]	new[34]	nonsal[34]	_	_	_	
13-6	614-617	old	person[34]	new[34]	nonsal[34]	_	_	_	
13-7	618-623	white	person[34]	new[34]	nonsal[34]	_	_	_	
13-8	624-628	male	person[34]	new[34]	nonsal[34]	_	_	_	
13-9	629-638	diagnosed	person[34]	new[34]	nonsal[34]	_	_	_	
13-10	639-643	with	person[34]	new[34]	nonsal[34]	_	_	_	
13-11	644-648	PTLD	person[34]|abstract[35]	new[34]|new[35]	nonsal[34]|nonsal[35]	Post-transplant_lymphoproliferative_disorder[35]	_	_	
13-12	649-651	in	person[34]	new[34]	nonsal[34]	_	_	_	
13-13	652-658	latter	person[34]|time[36]	new[34]|giv[36]	nonsal[34]|nonsal[36]	_	_	_	
13-14	659-663	half	person[34]|time[36]	new[34]|giv[36]	nonsal[34]|nonsal[36]	_	_	_	
13-15	664-666	of	person[34]|time[36]	new[34]|giv[36]	nonsal[34]|nonsal[36]	_	_	_	
13-16	667-671	2007	person[34]|time[36]|time[37]	new[34]|giv[36]|new[37]	nonsal[34]|nonsal[36]|sal[37]	_	_	_	
13-17	672-673	.	_	_	_	_	_	_	

#Text=He presented with symptoms of increasing adenopathy , abdominal pain , weight loss , and anorexia .
14-1	674-676	He	person[38]	giv[38]	nonsal[38]	_	coref	15-1[45_38]	
14-2	677-686	presented	_	_	_	_	_	_	
14-3	687-691	with	_	_	_	_	_	_	
14-4	692-700	symptoms	abstract[39]	new[39]	nonsal[39]	_	_	_	
14-5	701-703	of	abstract[39]	new[39]	nonsal[39]	_	_	_	
14-6	704-714	increasing	abstract[39]|abstract[40]	new[39]|new[40]	nonsal[39]|nonsal[40]	_	coref	35-6[132_40]	
14-7	715-725	adenopathy	abstract[39]|abstract[40]	new[39]|new[40]	nonsal[39]|nonsal[40]	_	_	_	
14-8	726-727	,	_	_	_	_	_	_	
14-9	728-737	abdominal	abstract[41]	new[41]	nonsal[41]	_	_	_	
14-10	738-742	pain	abstract[41]	new[41]	nonsal[41]	_	_	_	
14-11	743-744	,	_	_	_	_	_	_	
14-12	745-751	weight	abstract[42]|abstract[43]	new[42]|new[43]	nonsal[42]|nonsal[43]	_	coref	33-10[126_43]	
14-13	752-756	loss	abstract[42]	new[42]	nonsal[42]	_	_	_	
14-14	757-758	,	_	_	_	_	_	_	
14-15	759-762	and	_	_	_	_	_	_	
14-16	763-771	anorexia	abstract[44]	new[44]	nonsal[44]	_	_	_	
14-17	772-773	.	_	_	_	_	_	_	

#Text=He did not seek medical attention immediately .
15-1	774-776	He	person[45]	giv[45]	nonsal[45]	_	coref	16-1[47_45]	
15-2	777-780	did	_	_	_	_	_	_	
15-3	781-784	not	_	_	_	_	_	_	
15-4	785-789	seek	_	_	_	_	_	_	
15-5	790-797	medical	abstract[46]	new[46]	nonsal[46]	_	_	_	
15-6	798-807	attention	abstract[46]	new[46]	nonsal[46]	_	_	_	
15-7	808-819	immediately	_	_	_	_	_	_	
15-8	820-821	.	_	_	_	_	_	_	

#Text=He was finally hospitalized by the renal transplant service and underwent a lymph node biopsy in the groin , which showed diagnosis of large cell lymphoma .
16-1	822-824	He	person[47]	giv[47]	nonsal[47]	_	coref	17-1[56_47]	
16-2	825-828	was	_	_	_	_	_	_	
16-3	829-836	finally	_	_	_	_	_	_	
16-4	837-849	hospitalized	_	_	_	_	_	_	
16-5	850-852	by	_	_	_	_	_	_	
16-6	853-856	the	_	_	_	_	_	_	
16-7	857-862	renal	abstract[48]|event[49]|object[50]	new[48]|new[49]|giv[50]	nonsal[48]|nonsal[49]|nonsal[50]	_	coref|coref	40-1[144_49]|40-1[145_50]	
16-8	863-873	transplant	abstract[48]|event[49]	new[48]|new[49]	nonsal[48]|nonsal[49]	_	_	_	
16-9	874-881	service	abstract[48]	new[48]	nonsal[48]	_	_	_	
16-10	882-885	and	_	_	_	_	_	_	
16-11	886-895	underwent	_	_	_	_	_	_	
16-12	896-897	a	event[51]	new[51]	nonsal[51]	_	_	_	
16-13	898-903	lymph	event[51]|object[52]	new[51]|new[52]	nonsal[51]|nonsal[52]	_	_	_	
16-14	904-908	node	event[51]|object[52]	new[51]|new[52]	nonsal[51]|nonsal[52]	_	_	_	
16-15	909-915	biopsy	event[51]	new[51]	nonsal[51]	_	_	_	
16-16	916-918	in	event[51]	new[51]	nonsal[51]	_	_	_	
16-17	919-922	the	event[51]|object[53]	new[51]|new[53]	nonsal[51]|nonsal[53]	_	_	_	
16-18	923-928	groin	event[51]|object[53]	new[51]|new[53]	nonsal[51]|nonsal[53]	_	_	_	
16-19	929-930	,	event[51]	new[51]	nonsal[51]	_	_	_	
16-20	931-936	which	event[51]	new[51]	nonsal[51]	_	_	_	
16-21	937-943	showed	event[51]	new[51]	nonsal[51]	_	_	_	
16-22	944-953	diagnosis	event[51]|abstract[54]	new[51]|new[54]	nonsal[51]|nonsal[54]	_	_	_	
16-23	954-956	of	event[51]|abstract[54]	new[51]|new[54]	nonsal[51]|nonsal[54]	_	_	_	
16-24	957-962	large	event[51]|abstract[54]|object[55]	new[51]|new[54]|new[55]	nonsal[51]|nonsal[54]|sal[55]	_	coref	45-3[170_55]	
16-25	963-967	cell	event[51]|abstract[54]|object[55]	new[51]|new[54]|new[55]	nonsal[51]|nonsal[54]|sal[55]	_	_	_	
16-26	968-976	lymphoma	event[51]|abstract[54]|object[55]	new[51]|new[54]|new[55]	nonsal[51]|nonsal[54]|sal[55]	_	_	_	
16-27	977-978	.	_	_	_	_	_	_	

#Text=He was discussed at the hematopathology conference .
17-1	979-981	He	person[56]	giv[56]	nonsal[56]	_	coref	20-1[70_56]	
17-2	982-985	was	_	_	_	_	_	_	
17-3	986-995	discussed	_	_	_	_	_	_	
17-4	996-998	at	_	_	_	_	_	_	
17-5	999-1002	the	event[57]	new[57]	nonsal[57]	_	_	_	
17-6	1003-1018	hematopathology	event[57]|abstract[58]	new[57]|new[58]	nonsal[57]|nonsal[58]	_	_	_	
17-7	1019-1029	conference	event[57]	new[57]	nonsal[57]	_	_	_	
17-8	1030-1031	.	_	_	_	_	_	_	

#Text=Chemotherapy with rituximab plus cyclophosphamide , daunorubicin , vincristine , and prednisone was started .
18-1	1032-1044	Chemotherapy	event[59]	new[59]	nonsal[59]	_	coref	19-4[66_59]	
18-2	1045-1049	with	event[59]	new[59]	nonsal[59]	_	_	_	
18-3	1050-1059	rituximab	event[59]|substance[60]	new[59]|new[60]	nonsal[59]|nonsal[60]	_	_	_	
18-4	1060-1064	plus	event[59]	new[59]	nonsal[59]	_	_	_	
18-5	1065-1081	cyclophosphamide	event[59]|substance[61]	new[59]|new[61]	nonsal[59]|nonsal[61]	_	_	_	
18-6	1082-1083	,	event[59]	new[59]	nonsal[59]	_	_	_	
18-7	1084-1096	daunorubicin	event[59]|substance[62]	new[59]|new[62]	nonsal[59]|nonsal[62]	_	_	_	
18-8	1097-1098	,	event[59]	new[59]	nonsal[59]	_	_	_	
18-9	1099-1110	vincristine	event[59]|substance[63]	new[59]|new[63]	nonsal[59]|nonsal[63]	_	_	_	
18-10	1111-1112	,	event[59]	new[59]	nonsal[59]	_	_	_	
18-11	1113-1116	and	event[59]	new[59]	nonsal[59]	_	_	_	
18-12	1117-1127	prednisone	event[59]|substance[64]	new[59]|new[64]	nonsal[59]|nonsal[64]	_	_	_	
18-13	1128-1131	was	_	_	_	_	_	_	
18-14	1132-1139	started	_	_	_	_	_	_	
18-15	1140-1141	.	_	_	_	_	_	_	

#Text=First cycle of chemotherapy was complicated by sepsis despite growth factor support .
19-1	1142-1147	First	abstract[65]	giv[65]	nonsal[65]	_	_	_	
19-2	1148-1153	cycle	abstract[65]	giv[65]	nonsal[65]	_	_	_	
19-3	1154-1156	of	abstract[65]	giv[65]	nonsal[65]	_	_	_	
19-4	1157-1169	chemotherapy	abstract[65]|event[66]	giv[65]|giv[66]	nonsal[65]|nonsal[66]	_	coref	21-8[76_66]	
19-5	1170-1173	was	_	_	_	_	_	_	
19-6	1174-1185	complicated	_	_	_	_	_	_	
19-7	1186-1188	by	_	_	_	_	_	_	
19-8	1189-1195	sepsis	abstract[67]	new[67]	nonsal[67]	_	coref	20-11[71_67]	
19-9	1196-1203	despite	_	_	_	_	_	_	
19-10	1204-1210	growth	abstract[68]|abstract[69]	new[68]|new[69]	nonsal[68]|nonsal[69]	_	coref|coref	51-9[196_68]|51-9[197_69]	
19-11	1211-1217	factor	abstract[68]|abstract[69]	new[68]|new[69]	nonsal[68]|nonsal[69]	_	_	_	
19-12	1218-1225	support	abstract[68]	new[68]	nonsal[68]	_	_	_	
19-13	1226-1227	.	_	_	_	_	_	_	

#Text=He also appeared to have become disoriented either secondary to sepsis or steroid therapy .
20-1	1228-1230	He	person[70]	giv[70]	nonsal[70]	_	coref	21-1[74_70]	
20-2	1231-1235	also	_	_	_	_	_	_	
20-3	1236-1244	appeared	_	_	_	_	_	_	
20-4	1245-1247	to	_	_	_	_	_	_	
20-5	1248-1252	have	_	_	_	_	_	_	
20-6	1253-1259	become	_	_	_	_	_	_	
20-7	1260-1271	disoriented	_	_	_	_	_	_	
20-8	1272-1278	either	_	_	_	_	_	_	
20-9	1279-1288	secondary	_	_	_	_	_	_	
20-10	1289-1291	to	_	_	_	_	_	_	
20-11	1292-1298	sepsis	abstract[71]	giv[71]	nonsal[71]	_	_	_	
20-12	1299-1301	or	_	_	_	_	_	_	
20-13	1302-1309	steroid	abstract[72]|substance[73]	new[72]|new[73]	nonsal[72]|nonsal[73]	_	_	_	
20-14	1310-1317	therapy	abstract[72]	new[72]	nonsal[72]	_	_	_	
20-15	1318-1319	.	_	_	_	_	_	_	

#Text=The patient has received 5 cycles of chemotherapy to date .
21-1	1320-1323	The	person[74]	giv[74]	nonsal[74]	_	coref	22-1[77_74]	
21-2	1324-1331	patient	person[74]	giv[74]	nonsal[74]	_	_	_	
21-3	1332-1335	has	_	_	_	_	_	_	
21-4	1336-1344	received	_	_	_	_	_	_	
21-5	1345-1346	5	abstract[75]	new[75]	nonsal[75]	_	_	_	
21-6	1347-1353	cycles	abstract[75]	new[75]	nonsal[75]	_	_	_	
21-7	1354-1356	of	abstract[75]	new[75]	nonsal[75]	_	_	_	
21-8	1357-1369	chemotherapy	abstract[75]|event[76]	new[75]|giv[76]	nonsal[75]|nonsal[76]	_	coref	24-12[96_76]	
21-9	1370-1372	to	_	_	_	_	_	_	
21-10	1373-1377	date	_	_	_	_	_	_	
21-11	1378-1379	.	_	_	_	_	_	_	

#Text=He did not keep his appointment for a PET scan after 3 cycles because he was not feeling well .
22-1	1380-1382	He	person[77]	giv[77]	nonsal[77]	_	coref	22-5[79_77]	
22-2	1383-1386	did	_	_	_	_	_	_	
22-3	1387-1390	not	_	_	_	_	_	_	
22-4	1391-1395	keep	_	_	_	_	_	_	
22-5	1396-1399	his	event[78]|person[79]	new[78]|giv[79]	nonsal[78]|nonsal[79]	_	coref	22-15[83_79]	
22-6	1400-1411	appointment	event[78]	new[78]	nonsal[78]	_	_	_	
22-7	1412-1415	for	event[78]	new[78]	nonsal[78]	_	_	_	
22-8	1416-1417	a	event[78]|abstract[80]	new[78]|new[80]	nonsal[78]|nonsal[80]	_	coref	47-1[178_80]	
22-9	1418-1421	PET	event[78]|abstract[80]|abstract[81]	new[78]|new[80]|new[81]	nonsal[78]|nonsal[80]|nonsal[81]	_	coref	47-1[179_81]	
22-10	1422-1426	scan	event[78]|abstract[80]	new[78]|new[80]	nonsal[78]|nonsal[80]	_	_	_	
22-11	1427-1432	after	event[78]	new[78]	nonsal[78]	_	_	_	
22-12	1433-1434	3	event[78]|abstract[82]	new[78]|new[82]	nonsal[78]|nonsal[82]	_	_	_	
22-13	1435-1441	cycles	event[78]|abstract[82]	new[78]|new[82]	nonsal[78]|nonsal[82]	_	_	_	
22-14	1442-1449	because	_	_	_	_	_	_	
22-15	1450-1452	he	person[83]	giv[83]	nonsal[83]	_	coref	23-1[85_83]	
22-16	1453-1456	was	_	_	_	_	_	_	
22-17	1457-1460	not	_	_	_	_	_	_	
22-18	1461-1468	feeling	_	_	_	_	_	_	
22-19	1469-1473	well	_	_	_	_	_	_	
22-20	1474-1475	.	_	_	_	_	_	_	

#Text=His therapy has been interrupted for infection related to squamous cell cancer , skin surgery as well as complaints of chest infection .
23-1	1476-1479	His	abstract[84]|person[85]	giv[84]|giv[85]	nonsal[84]|nonsal[85]	_	coref	24-1[93_85]	
23-2	1480-1487	therapy	abstract[84]	giv[84]	nonsal[84]	_	_	_	
23-3	1488-1491	has	_	_	_	_	_	_	
23-4	1492-1496	been	_	_	_	_	_	_	
23-5	1497-1508	interrupted	_	_	_	_	_	_	
23-6	1509-1512	for	_	_	_	_	_	_	
23-7	1513-1522	infection	event[86]	new[86]	nonsal[86]	_	_	_	
23-8	1523-1530	related	event[86]	new[86]	nonsal[86]	_	_	_	
23-9	1531-1533	to	event[86]	new[86]	nonsal[86]	_	_	_	
23-10	1534-1542	squamous	event[86]|abstract[87]|animal[88]	new[86]|new[87]|giv[88]	nonsal[86]|nonsal[87]|nonsal[88]	_	coref|coref	55-2[212_87]|55-2[214_88]	
23-11	1543-1547	cell	event[86]|abstract[87]|animal[88]	new[86]|new[87]|giv[88]	nonsal[86]|nonsal[87]|nonsal[88]	_	_	_	
23-12	1548-1554	cancer	event[86]|abstract[87]	new[86]|new[87]	nonsal[86]|nonsal[87]	_	_	_	
23-13	1555-1556	,	_	_	_	_	_	_	
23-14	1557-1561	skin	event[89]|object[90]	new[89]|giv[90]	nonsal[89]|nonsal[90]	_	coref	55-6[215_90]	
23-15	1562-1569	surgery	event[89]	new[89]	nonsal[89]	_	_	_	
23-16	1570-1572	as	_	_	_	_	_	_	
23-17	1573-1577	well	_	_	_	_	_	_	
23-18	1578-1580	as	_	_	_	_	_	_	
23-19	1581-1591	complaints	event[91]	new[91]	nonsal[91]	_	_	_	
23-20	1592-1594	of	event[91]	new[91]	nonsal[91]	_	_	_	
23-21	1595-1600	chest	event[91]|object[92]	new[91]|new[92]	nonsal[91]|nonsal[92]	_	coref	26-14[107_92]	
23-22	1601-1610	infection	event[91]	new[91]	nonsal[91]	_	_	_	
23-23	1611-1612	.	_	_	_	_	_	_	

#Text=The patient is here for the sixth and final cycle of chemotherapy .
24-1	1613-1616	The	person[93]	giv[93]	nonsal[93]	_	coref	25-1[97_93]	
24-2	1617-1624	patient	person[93]	giv[93]	nonsal[93]	_	_	_	
24-3	1625-1627	is	_	_	_	_	_	_	
24-4	1628-1632	here	place[94]	new[94]	nonsal[94]	_	_	_	
24-5	1633-1636	for	_	_	_	_	_	_	
24-6	1637-1640	the	abstract[95]	new[95]	nonsal[95]	_	_	_	
24-7	1641-1646	sixth	abstract[95]	new[95]	nonsal[95]	_	_	_	
24-8	1647-1650	and	abstract[95]	new[95]	nonsal[95]	_	_	_	
24-9	1651-1656	final	abstract[95]	new[95]	nonsal[95]	_	_	_	
24-10	1657-1662	cycle	abstract[95]	new[95]	nonsal[95]	_	_	_	
24-11	1663-1665	of	abstract[95]	new[95]	nonsal[95]	_	_	_	
24-12	1666-1678	chemotherapy	abstract[95]|event[96]	new[95]|giv[96]	nonsal[95]|nonsal[96]	_	coref	46-12[176_96]	
24-13	1679-1680	.	_	_	_	_	_	_	

#Text=He states he feels well .
25-1	1681-1683	He	person[97]	giv[97]	nonsal[97]	_	coref	25-3[98_97]	
25-2	1684-1690	states	_	_	_	_	_	_	
25-3	1691-1693	he	person[98]	giv[98]	nonsal[98]	_	coref	26-1[99_98]	
25-4	1694-1699	feels	_	_	_	_	_	_	
25-5	1700-1704	well	_	_	_	_	_	_	
25-6	1705-1706	.	_	_	_	_	_	_	

#Text=He denies any nausea , vomiting , cough , shortness of breath , chest pain or fatigue .
26-1	1707-1709	He	person[99]	giv[99]	nonsal[99]	_	coref	27-1[109_99]	
26-2	1710-1716	denies	_	_	_	_	_	_	
26-3	1717-1720	any	abstract[100]	new[100]	nonsal[100]	_	_	_	
26-4	1721-1727	nausea	abstract[100]|abstract[101]	new[100]|new[101]	nonsal[100]|nonsal[101]	_	_	_	
26-5	1728-1729	,	_	_	_	_	_	_	
26-6	1730-1738	vomiting	event[102]	new[102]	nonsal[102]	_	_	_	
26-7	1739-1740	,	_	_	_	_	_	_	
26-8	1741-1746	cough	event[103]	new[103]	nonsal[103]	_	_	_	
26-9	1747-1748	,	_	_	_	_	_	_	
26-10	1749-1758	shortness	abstract[104]	new[104]	nonsal[104]	_	_	_	
26-11	1759-1761	of	abstract[104]	new[104]	nonsal[104]	_	_	_	
26-12	1762-1768	breath	abstract[104]|abstract[105]	new[104]|new[105]	nonsal[104]|nonsal[105]	_	_	_	
26-13	1769-1770	,	_	_	_	_	_	_	
26-14	1771-1776	chest	abstract[106]|object[107]	giv[106]|giv[107]	nonsal[106]|nonsal[107]	_	coref	36-1[134_107]	
26-15	1777-1781	pain	abstract[106]	giv[106]	nonsal[106]	_	_	_	
26-16	1782-1784	or	_	_	_	_	_	_	
26-17	1785-1792	fatigue	abstract[108]	new[108]	nonsal[108]	_	_	_	
26-18	1793-1794	.	_	_	_	_	_	_	

#Text=He denies any tingling or numbness in his fingers .
27-1	1795-1797	He	person[109]	giv[109]	nonsal[109]	_	coref	27-8[112_109]	
27-2	1798-1804	denies	_	_	_	_	_	_	
27-3	1805-1808	any	abstract[110]	new[110]	nonsal[110]	_	_	_	
27-4	1809-1817	tingling	abstract[110]	new[110]	nonsal[110]	_	_	_	
27-5	1818-1820	or	abstract[110]	new[110]	nonsal[110]	_	_	_	
27-6	1821-1829	numbness	abstract[110]	new[110]	nonsal[110]	_	_	_	
27-7	1830-1832	in	abstract[110]	new[110]	nonsal[110]	_	_	_	
27-8	1833-1836	his	abstract[110]|object[111]|person[112]	new[110]|new[111]|giv[112]	nonsal[110]|nonsal[111]|nonsal[112]	_	coref	32-1[120_112]	
27-9	1837-1844	fingers	abstract[110]|object[111]	new[110]|new[111]	nonsal[110]|nonsal[111]	_	_	_	
27-10	1845-1846	.	_	_	_	_	_	_	

#Text=Review of systems is otherwise entirely negative .
28-1	1847-1853	Review	abstract[113]	giv[113]	nonsal[113]	_	_	_	
28-2	1854-1856	of	abstract[113]	giv[113]	nonsal[113]	_	_	_	
28-3	1857-1864	systems	abstract[113]|abstract[114]	giv[113]|new[114]	nonsal[113]|nonsal[114]	_	_	_	
28-4	1865-1867	is	_	_	_	_	_	_	
28-5	1868-1877	otherwise	_	_	_	_	_	_	
28-6	1878-1886	entirely	_	_	_	_	_	_	
28-7	1887-1895	negative	_	_	_	_	_	_	
28-8	1896-1897	.	_	_	_	_	_	_	

#Text=Performance status on the ECOG scale is 1
29-1	1898-1909	Performance	abstract[115]	new[115]	nonsal[115]	_	coref	29-8[117_115]	
29-2	1910-1916	status	abstract[115]	new[115]	nonsal[115]	_	_	_	
29-3	1917-1919	on	abstract[115]	new[115]	nonsal[115]	_	_	_	
29-4	1920-1923	the	abstract[115]|abstract[116]	new[115]|new[116]	nonsal[115]|nonsal[116]	_	_	_	
29-5	1924-1928	ECOG	abstract[115]|abstract[116]	new[115]|new[116]	nonsal[115]|nonsal[116]	_	_	_	
29-6	1929-1934	scale	abstract[115]|abstract[116]	new[115]|new[116]	nonsal[115]|nonsal[116]	_	_	_	
29-7	1935-1937	is	_	_	_	_	_	_	
29-8	1938-1939	1	abstract[117]	giv[117]	nonsal[117]	_	_	_	

#Text=PHYSICAL EXAMINATION :
30-1	1940-1948	PHYSICAL	abstract[118]	new[118]	nonsal[118]	_	_	_	
30-2	1949-1960	EXAMINATION	abstract[118]	new[118]	nonsal[118]	_	_	_	
30-3	1961-1962	:	_	_	_	_	_	_	

#Text=VITAL SIGNS :
31-1	1963-1968	VITAL	abstract[119]	new[119]	nonsal[119]	_	_	_	
31-2	1969-1974	SIGNS	abstract[119]	new[119]	nonsal[119]	_	_	_	
31-3	1975-1976	:	_	_	_	_	_	_	

#Text=He is afebrile .
32-1	1977-1979	He	person[120]	giv[120]	nonsal[120]	_	coref	33-19[129_120]	
32-2	1980-1982	is	_	_	_	_	_	_	
32-3	1983-1991	afebrile	_	_	_	_	_	_	
32-4	1992-1993	.	_	_	_	_	_	_	

#Text=Blood pressure 161 / 80 , pulse 65 , weight 71.5 kg , which is essentially unchanged from his prior visit .
33-1	1994-1999	Blood	abstract[121]|substance[122]	new[121]|new[122]	nonsal[121]|nonsal[122]	_	coref	33-3[123_121]	
33-2	2000-2008	pressure	abstract[121]	new[121]	nonsal[121]	_	_	_	
33-3	2009-2012	161	abstract[123]	new[123]	nonsal[123]	_	_	_	
33-4	2013-2014	/	abstract[123]	new[123]	nonsal[123]	_	_	_	
33-5	2015-2017	80	abstract[123]	new[123]	nonsal[123]	_	_	_	
33-6	2018-2019	,	_	_	_	_	_	_	
33-7	2020-2025	pulse	abstract[124]	new[124]	nonsal[124]	_	coref	33-8[125_124]	
33-8	2026-2028	65	abstract[125]	giv[125]	nonsal[125]	_	_	_	
33-9	2029-2030	,	_	_	_	_	_	_	
33-10	2031-2037	weight	abstract[126]	giv[126]	nonsal[126]	_	coref	33-11[127_126]	
33-11	2038-2042	71.5	abstract[127]	new[127]	nonsal[127]	_	_	_	
33-12	2043-2045	kg	abstract[127]	new[127]	nonsal[127]	_	_	_	
33-13	2046-2047	,	_	_	_	_	_	_	
33-14	2048-2053	which	_	_	_	_	_	_	
33-15	2054-2056	is	_	_	_	_	_	_	
33-16	2057-2068	essentially	_	_	_	_	_	_	
33-17	2069-2078	unchanged	_	_	_	_	_	_	
33-18	2079-2083	from	_	_	_	_	_	_	
33-19	2084-2087	his	event[128]|person[129]	new[128]|giv[129]	nonsal[128]|nonsal[129]	_	coref	46-1[173_129]	
33-20	2088-2093	prior	event[128]	new[128]	nonsal[128]	_	_	_	
33-21	2094-2099	visit	event[128]	new[128]	nonsal[128]	_	_	_	
33-22	2100-2101	.	_	_	_	_	_	_	

#Text=There is mild pallor noted .
34-1	2102-2107	There	_	_	_	_	_	_	
34-2	2108-2110	is	_	_	_	_	_	_	
34-3	2111-2115	mild	abstract[130]	new[130]	nonsal[130]	_	_	_	
34-4	2116-2122	pallor	abstract[130]	new[130]	nonsal[130]	_	_	_	
34-5	2123-2128	noted	_	_	_	_	_	_	
34-6	2129-2130	.	_	_	_	_	_	_	

#Text=There is no icterus , adenopathy or petechiae noted .
35-1	2131-2136	There	_	_	_	_	_	_	
35-2	2137-2139	is	_	_	_	_	_	_	
35-3	2140-2142	no	_	_	_	_	_	_	
35-4	2143-2150	icterus	abstract[131]	new[131]	nonsal[131]	_	_	_	
35-5	2151-2152	,	_	_	_	_	_	_	
35-6	2153-2163	adenopathy	abstract[132]	giv[132]	nonsal[132]	_	_	_	
35-7	2164-2166	or	_	_	_	_	_	_	
35-8	2167-2176	petechiae	object[133]	new[133]	nonsal[133]	_	_	_	
35-9	2177-2182	noted	_	_	_	_	_	_	
35-10	2183-2184	.	_	_	_	_	_	_	

#Text=CHEST : Clear to auscultation .
36-1	2185-2190	CHEST	object[134]	giv[134]	nonsal[134]	_	_	_	
36-2	2191-2192	:	_	_	_	_	_	_	
36-3	2193-2198	Clear	_	_	_	_	_	_	
36-4	2199-2201	to	_	_	_	_	_	_	
36-5	2202-2214	auscultation	event[135]	new[135]	nonsal[135]	_	_	_	
36-6	2215-2216	.	_	_	_	_	_	_	

#Text=CARDIOVASCULAR : S1 and S2 normal with regular rate and rhythm .
37-1	2217-2231	CARDIOVASCULAR	abstract[136]	new[136]	nonsal[136]	_	_	_	
37-2	2232-2233	:	_	_	_	_	_	_	
37-3	2234-2236	S1	abstract[137]	new[137]	nonsal[137]	_	_	_	
37-4	2237-2240	and	_	_	_	_	_	_	
37-5	2241-2243	S2	abstract[138]	new[138]	nonsal[138]	_	_	_	
37-6	2244-2250	normal	_	_	_	_	_	_	
37-7	2251-2255	with	_	_	_	_	_	_	
37-8	2256-2263	regular	event[139]	new[139]	nonsal[139]	_	_	_	
37-9	2264-2268	rate	event[139]	new[139]	nonsal[139]	_	_	_	
37-10	2269-2272	and	event[139]	new[139]	nonsal[139]	_	_	_	
37-11	2273-2279	rhythm	event[139]	new[139]	nonsal[139]	_	_	_	
37-12	2280-2281	.	_	_	_	_	_	_	

#Text=Systolic flow murmur is best heard in the pulmonary area .
38-1	2282-2290	Systolic	event[140]	new[140]	nonsal[140]	_	_	_	
38-2	2291-2295	flow	event[140]	new[140]	nonsal[140]	_	_	_	
38-3	2296-2302	murmur	event[140]	new[140]	nonsal[140]	_	_	_	
38-4	2303-2305	is	_	_	_	_	_	_	
38-5	2306-2310	best	_	_	_	_	_	_	
38-6	2311-2316	heard	_	_	_	_	_	_	
38-7	2317-2319	in	_	_	_	_	_	_	
38-8	2320-2323	the	place[141]	new[141]	nonsal[141]	_	_	_	
38-9	2324-2333	pulmonary	place[141]	new[141]	nonsal[141]	_	_	_	
38-10	2334-2338	area	place[141]	new[141]	nonsal[141]	_	_	_	
38-11	2339-2340	.	_	_	_	_	_	_	

#Text=ABDOMEN : Soft and nontender with no organomegaly .
39-1	2341-2348	ABDOMEN	object[142]	new[142]	nonsal[142]	_	_	_	
39-2	2349-2350	:	_	_	_	_	_	_	
39-3	2351-2355	Soft	_	_	_	_	_	_	
39-4	2356-2359	and	_	_	_	_	_	_	
39-5	2360-2369	nontender	_	_	_	_	_	_	
39-6	2370-2374	with	_	_	_	_	_	_	
39-7	2375-2377	no	_	_	_	_	_	_	
39-8	2378-2390	organomegaly	event[143]	new[143]	nonsal[143]	_	_	_	
39-9	2391-2392	.	_	_	_	_	_	_	

#Text=Renal transplant is noted in the right lower quadrant with a scar present .
40-1	2393-2398	Renal	event[144]|object[145]	new[144]|giv[145]	nonsal[144]|nonsal[145]	_	coref	50-6[191_145]	
40-2	2399-2409	transplant	event[144]	new[144]	nonsal[144]	_	_	_	
40-3	2410-2412	is	_	_	_	_	_	_	
40-4	2413-2418	noted	_	_	_	_	_	_	
40-5	2419-2421	in	_	_	_	_	_	_	
40-6	2422-2425	the	object[146]	new[146]	nonsal[146]	_	_	_	
40-7	2426-2431	right	object[146]	new[146]	nonsal[146]	_	_	_	
40-8	2432-2437	lower	object[146]	new[146]	nonsal[146]	_	_	_	
40-9	2438-2446	quadrant	object[146]	new[146]	nonsal[146]	_	_	_	
40-10	2447-2451	with	_	_	_	_	_	_	
40-11	2452-2453	a	object[147]	new[147]	nonsal[147]	_	_	_	
40-12	2454-2458	scar	object[147]	new[147]	nonsal[147]	_	_	_	
40-13	2459-2466	present	_	_	_	_	_	_	
40-14	2467-2468	.	_	_	_	_	_	_	

#Text=EXTREMITIES : Reveal no edema .
41-1	2469-2480	EXTREMITIES	abstract[148]	new[148]	nonsal[148]	_	_	_	
41-2	2481-2482	:	_	_	_	_	_	_	
41-3	2483-2489	Reveal	_	_	_	_	_	_	
41-4	2490-2492	no	abstract[149]	new[149]	nonsal[149]	_	_	_	
41-5	2493-2498	edema	abstract[149]	new[149]	nonsal[149]	_	_	_	
41-6	2499-2500	.	_	_	_	_	_	_	

#Text=LABORATORY DATA :
42-1	2501-2511	LABORATORY	abstract[150]	new[150]	nonsal[150]	_	_	_	
42-2	2512-2516	DATA	abstract[150]	new[150]	nonsal[150]	_	_	_	
42-3	2517-2518	:	_	_	_	_	_	_	

#Text=CBC from today shows white count of 9.6 with a normal differential , ANC of 7400 , hemoglobin 8.9 , hematocrit 26.5 with an MCV of 109 , and platelet count of 220,000 .
43-1	2519-2522	CBC	abstract[151]|abstract[152]	new[151]|new[152]	nonsal[151]|nonsal[152]	Complete_blood_count[152]	coref	48-13[185_152]	
43-2	2523-2527	from	abstract[151]	new[151]	nonsal[151]	_	_	_	
43-3	2528-2533	today	abstract[151]|time[153]	new[151]|acc[153]	nonsal[151]|nonsal[153]	_	coref	46-13[177_153]	
43-4	2534-2539	shows	_	_	_	_	_	_	
43-5	2540-2545	white	abstract[154]	new[154]	nonsal[154]	_	coref	43-8[155_154]	
43-6	2546-2551	count	abstract[154]	new[154]	nonsal[154]	_	_	_	
43-7	2552-2554	of	abstract[154]	new[154]	nonsal[154]	_	_	_	
43-8	2555-2558	9.6	abstract[154]|abstract[155]	new[154]|new[155]	nonsal[154]|nonsal[155]	_	_	_	
43-9	2559-2563	with	abstract[154]	new[154]	nonsal[154]	_	_	_	
43-10	2564-2565	a	abstract[154]|abstract[156]	new[154]|new[156]	nonsal[154]|nonsal[156]	_	_	_	
43-11	2566-2572	normal	abstract[154]|abstract[156]	new[154]|new[156]	nonsal[154]|nonsal[156]	_	_	_	
43-12	2573-2585	differential	abstract[154]|abstract[156]	new[154]|new[156]	nonsal[154]|nonsal[156]	_	_	_	
43-13	2586-2587	,	_	_	_	_	_	_	
43-14	2588-2591	ANC	abstract[157]	new[157]	nonsal[157]	_	coref	43-16[158_157]	
43-15	2592-2594	of	_	_	_	_	_	_	
43-16	2595-2599	7400	abstract[158]	new[158]	nonsal[158]	_	_	_	
43-17	2600-2601	,	_	_	_	_	_	_	
43-18	2602-2612	hemoglobin	abstract[159]	new[159]	nonsal[159]	_	coref	43-19[160_159]	
43-19	2613-2616	8.9	abstract[160]	giv[160]	nonsal[160]	_	_	_	
43-20	2617-2618	,	_	_	_	_	_	_	
43-21	2619-2629	hematocrit	abstract[161]	new[161]	nonsal[161]	_	coref	43-22[162_161]	
43-22	2630-2634	26.5	abstract[162]	giv[162]	nonsal[162]	_	_	_	
43-23	2635-2639	with	_	_	_	_	_	_	
43-24	2640-2642	an	abstract[163]	new[163]	nonsal[163]	_	coref	43-27[164_163]	
43-25	2643-2646	MCV	abstract[163]	new[163]	nonsal[163]	_	_	_	
43-26	2647-2649	of	abstract[163]	new[163]	nonsal[163]	_	_	_	
43-27	2650-2653	109	abstract[163]|abstract[164]	new[163]|new[164]	nonsal[163]|nonsal[164]	_	_	_	
43-28	2654-2655	,	_	_	_	_	_	_	
43-29	2656-2659	and	_	_	_	_	_	_	
43-30	2660-2668	platelet	abstract[165]|object[166]	new[165]|new[166]	nonsal[165]|nonsal[166]	_	coref	43-33[167_165]	
43-31	2669-2674	count	abstract[165]	new[165]	nonsal[165]	_	_	_	
43-32	2675-2677	of	abstract[165]	new[165]	nonsal[165]	_	_	_	
43-33	2678-2685	220,000	abstract[165]|abstract[167]	new[165]|new[167]	nonsal[165]|nonsal[167]	_	_	_	
43-34	2686-2687	.	_	_	_	_	_	_	

#Text=ASSESSMENT AND PLAN :
44-1	2688-2698	ASSESSMENT	abstract[168]	new[168]	nonsal[168]	_	_	_	
44-2	2699-2702	AND	_	_	_	_	_	_	
44-3	2703-2707	PLAN	abstract[169]	new[169]	nonsal[169]	_	_	_	
44-4	2708-2709	:	_	_	_	_	_	_	

#Text=1. Diffuse large B - cell lymphoma following transplantation .
45-1	2710-2712	1.	_	_	_	_	_	_	
45-2	2713-2720	Diffuse	_	_	_	_	_	_	
45-3	2721-2726	large	object[170]	new[170]	nonsal[170]	_	_	_	
45-4	2727-2728	B	object[170]|object[171]	new[170]|new[171]	nonsal[170]|sal[171]	_	_	_	
45-5	2729-2730	-	object[170]|object[171]	new[170]|new[171]	nonsal[170]|sal[171]	_	_	_	
45-6	2731-2735	cell	object[170]|object[171]	new[170]|new[171]	nonsal[170]|sal[171]	_	_	_	
45-7	2736-2744	lymphoma	object[170]	new[170]	nonsal[170]	_	_	_	
45-8	2745-2754	following	_	_	_	_	_	_	
45-9	2755-2770	transplantation	event[172]	new[172]	sal[172]	_	_	_	
45-10	2771-2772	.	_	_	_	_	_	_	

#Text=The patient is to receive his sixth and final cycle of chemotherapy today .
46-1	2773-2776	The	person[173]	new[173]	nonsal[173]	_	coref	46-6[175_173]	
46-2	2777-2784	patient	person[173]	new[173]	nonsal[173]	_	_	_	
46-3	2785-2787	is	_	_	_	_	_	_	
46-4	2788-2790	to	_	_	_	_	_	_	
46-5	2791-2798	receive	_	_	_	_	_	_	
46-6	2799-2802	his	abstract[174]|person[175]	new[174]|giv[175]	nonsal[174]|nonsal[175]	_	coref	48-1[181_175]	
46-7	2803-2808	sixth	abstract[174]	new[174]	nonsal[174]	_	_	_	
46-8	2809-2812	and	abstract[174]	new[174]	nonsal[174]	_	_	_	
46-9	2813-2818	final	abstract[174]	new[174]	nonsal[174]	_	_	_	
46-10	2819-2824	cycle	abstract[174]	new[174]	nonsal[174]	_	_	_	
46-11	2825-2827	of	abstract[174]	new[174]	nonsal[174]	_	_	_	
46-12	2828-2840	chemotherapy	abstract[174]|event[176]	new[174]|new[176]	nonsal[174]|nonsal[176]	_	coref	50-9[192_176]	
46-13	2841-2846	today	time[177]	giv[177]	nonsal[177]	_	coref	53-4[200_177]	
46-14	2847-2848	.	_	_	_	_	_	_	

#Text=PET scan has been ordered to be done within 2 weeks .
47-1	2849-2852	PET	abstract[178]|abstract[179]	new[178]|new[179]	nonsal[178]|nonsal[179]	_	_	_	
47-2	2853-2857	scan	abstract[178]	new[178]	nonsal[178]	_	_	_	
47-3	2858-2861	has	_	_	_	_	_	_	
47-4	2862-2866	been	_	_	_	_	_	_	
47-5	2867-2874	ordered	_	_	_	_	_	_	
47-6	2875-2877	to	_	_	_	_	_	_	
47-7	2878-2880	be	_	_	_	_	_	_	
47-8	2881-2885	done	_	_	_	_	_	_	
47-9	2886-2892	within	_	_	_	_	_	_	
47-10	2893-2894	2	time[180]	new[180]	nonsal[180]	_	_	_	
47-11	2895-2900	weeks	time[180]	new[180]	nonsal[180]	_	_	_	
47-12	2901-2902	.	_	_	_	_	_	_	

#Text=He will see me back for the visit in 3 weeks with CBC , CMP , and LDH .
48-1	2903-2905	He	person[181]	giv[181]	nonsal[181]	_	coref	51-1[193_181]	
48-2	2906-2910	will	_	_	_	_	_	_	
48-3	2911-2914	see	_	_	_	_	_	_	
48-4	2915-2917	me	person[182]	acc[182]	nonsal[182]	_	_	_	
48-5	2918-2922	back	_	_	_	_	_	_	
48-6	2923-2926	for	_	_	_	_	_	_	
48-7	2927-2930	the	event[183]	giv[183]	sal[183]	_	_	_	
48-8	2931-2936	visit	event[183]	giv[183]	sal[183]	_	_	_	
48-9	2937-2939	in	event[183]	giv[183]	sal[183]	_	_	_	
48-10	2940-2941	3	event[183]|time[184]	giv[183]|new[184]	sal[183]|sal[184]	_	_	_	
48-11	2942-2947	weeks	event[183]|time[184]	giv[183]|new[184]	sal[183]|sal[184]	_	_	_	
48-12	2948-2952	with	_	_	_	_	_	_	
48-13	2953-2956	CBC	abstract[185]	giv[185]	nonsal[185]	Complete_blood_count[185]	_	_	
48-14	2957-2958	,	_	_	_	_	_	_	
48-15	2959-2962	CMP	abstract[186]	new[186]	nonsal[186]	Comprehensive_metabolic_panel[186]	coref	54-1[209_186]	
48-16	2963-2964	,	_	_	_	_	_	_	
48-17	2965-2968	and	_	_	_	_	_	_	
48-18	2969-2972	LDH	abstract[187]	new[187]	nonsal[187]	Lactate_dehydrogenase[187]	_	_	
48-19	2973-2974	.	_	_	_	_	_	_	

#Text=2. Chronic renal insufficiency .
49-1	2975-2977	2.	_	_	_	_	_	_	
49-2	2978-2985	Chronic	abstract[188]	new[188]	nonsal[188]	_	_	_	
49-3	2986-2991	renal	abstract[188]	new[188]	nonsal[188]	_	_	_	
49-4	2992-3005	insufficiency	abstract[188]	new[188]	nonsal[188]	_	_	_	
49-5	3006-3007	.	_	_	_	_	_	_	

#Text=3. Anemia secondary to chronic renal failure and chemotherapy .
50-1	3008-3010	3.	_	_	_	_	_	_	
50-2	3011-3017	Anemia	abstract[189]	new[189]	nonsal[189]	_	_	_	
50-3	3018-3027	secondary	abstract[189]	new[189]	nonsal[189]	_	_	_	
50-4	3028-3030	to	abstract[189]	new[189]	nonsal[189]	_	_	_	
50-5	3031-3038	chronic	abstract[189]|event[190]	new[189]|new[190]	nonsal[189]|nonsal[190]	_	_	_	
50-6	3039-3044	renal	abstract[189]|event[190]|object[191]	new[189]|new[190]|giv[191]	nonsal[189]|nonsal[190]|nonsal[191]	_	_	_	
50-7	3045-3052	failure	abstract[189]|event[190]	new[189]|new[190]	nonsal[189]|nonsal[190]	_	_	_	
50-8	3053-3056	and	abstract[189]	new[189]	nonsal[189]	_	_	_	
50-9	3057-3069	chemotherapy	abstract[189]|event[192]	new[189]|giv[192]	nonsal[189]|nonsal[192]	_	coref	59-9[227_192]	
50-10	3070-3071	.	_	_	_	_	_	_	

#Text=He is to continue on his regimen of growth factor support .
51-1	3072-3074	He	person[193]	giv[193]	nonsal[193]	_	coref	51-6[195_193]	
51-2	3075-3077	is	_	_	_	_	_	_	
51-3	3078-3080	to	_	_	_	_	_	_	
51-4	3081-3089	continue	_	_	_	_	_	_	
51-5	3090-3092	on	_	_	_	_	_	_	
51-6	3093-3096	his	abstract[194]|person[195]	new[194]|giv[195]	nonsal[194]|nonsal[195]	_	coref	53-6[202_195]	
51-7	3097-3104	regimen	abstract[194]	new[194]	nonsal[194]	_	_	_	
51-8	3105-3107	of	abstract[194]	new[194]	nonsal[194]	_	_	_	
51-9	3108-3114	growth	abstract[194]|abstract[196]|abstract[197]	new[194]|new[196]|new[197]	nonsal[194]|nonsal[196]|nonsal[197]	_	_	_	
51-10	3115-3121	factor	abstract[194]|abstract[196]|abstract[197]	new[194]|new[196]|new[197]	nonsal[194]|nonsal[196]|nonsal[197]	_	_	_	
51-11	3122-3129	support	abstract[194]|abstract[196]	new[194]|new[196]	nonsal[194]|nonsal[196]	_	_	_	
51-12	3130-3131	.	_	_	_	_	_	_	

#Text=4. Hypertension .
52-1	3132-3134	4.	_	_	_	_	_	_	
52-2	3135-3147	Hypertension	abstract[198]	new[198]	nonsal[198]	_	coref	53-1[199_198]	
52-3	3148-3149	.	_	_	_	_	_	_	

#Text=This is elevated today because he held his meds because he is getting rituximab other than that this is well controlled .
53-1	3150-3154	This	abstract[199]	giv[199]	nonsal[199]	_	coref	53-18[208_199]	
53-2	3155-3157	is	_	_	_	_	_	_	
53-3	3158-3166	elevated	_	_	_	_	_	_	
53-4	3167-3172	today	time[200]	giv[200]	nonsal[200]	_	coref	54-6[211_200]	
53-5	3173-3180	because	_	_	_	_	_	_	
53-6	3181-3183	he	event[201]|person[202]	new[201]|giv[202]	nonsal[201]|nonsal[202]	_	coref|coref	53-17[207_201]|53-8[204_202]	
53-7	3184-3188	held	event[201]	new[201]	nonsal[201]	_	_	_	
53-8	3189-3192	his	event[201]|substance[203]|person[204]	new[201]|new[203]|giv[204]	nonsal[201]|nonsal[203]|nonsal[204]	_	coref	53-11[205_204]	
53-9	3193-3197	meds	event[201]|substance[203]	new[201]|new[203]	nonsal[201]|nonsal[203]	_	_	_	
53-10	3198-3205	because	event[201]	new[201]	nonsal[201]	_	_	_	
53-11	3206-3208	he	event[201]|person[205]	new[201]|giv[205]	nonsal[201]|nonsal[205]	_	coref	54-1[210_205]	
53-12	3209-3211	is	event[201]	new[201]	nonsal[201]	_	_	_	
53-13	3212-3219	getting	event[201]	new[201]	nonsal[201]	_	_	_	
53-14	3220-3229	rituximab	event[201]|substance[206]	new[201]|new[206]	nonsal[201]|nonsal[206]	_	_	_	
53-15	3230-3235	other	_	_	_	_	_	_	
53-16	3236-3240	than	_	_	_	_	_	_	
53-17	3241-3245	that	event[207]	giv[207]	nonsal[207]	_	_	_	
53-18	3246-3250	this	abstract[208]	giv[208]	nonsal[208]	_	_	_	
53-19	3251-3253	is	_	_	_	_	_	_	
53-20	3254-3258	well	_	_	_	_	_	_	
53-21	3259-3269	controlled	_	_	_	_	_	_	
53-22	3270-3271	.	_	_	_	_	_	_	

#Text=His CMP is pending from today .
54-1	3272-3275	His	abstract[209]|person[210]	giv[209]|giv[210]	nonsal[209]|nonsal[210]	_	coref	57-1[217_210]	
54-2	3276-3279	CMP	abstract[209]	giv[209]	nonsal[209]	_	_	_	
54-3	3280-3282	is	_	_	_	_	_	_	
54-4	3283-3290	pending	_	_	_	_	_	_	
54-5	3291-3295	from	_	_	_	_	_	_	
54-6	3296-3301	today	time[211]	giv[211]	nonsal[211]	_	_	_	
54-7	3302-3303	.	_	_	_	_	_	_	

#Text=5. Squamous cell carcinoma of the skin .
55-1	3304-3306	5.	_	_	_	_	_	_	
55-2	3307-3315	Squamous	abstract[212]|abstract[213]|animal[214]	new[212]|giv[213]|giv[214]	nonsal[212]|nonsal[213]|nonsal[214]	_	coref	55-2[213_212]	
55-3	3316-3320	cell	abstract[212]|abstract[213]|animal[214]	new[212]|giv[213]|giv[214]	nonsal[212]|nonsal[213]|nonsal[214]	_	_	_	
55-4	3321-3330	carcinoma	abstract[212]|abstract[213]	new[212]|giv[213]	nonsal[212]|nonsal[213]	_	_	_	
55-5	3331-3333	of	abstract[212]	new[212]	nonsal[212]	_	_	_	
55-6	3334-3337	the	abstract[212]|object[215]	new[212]|new[215]	nonsal[212]|nonsal[215]	_	_	_	
55-7	3338-3342	skin	abstract[212]|object[215]	new[212]|new[215]	nonsal[212]|nonsal[215]	_	_	_	
55-8	3343-3344	.	_	_	_	_	_	_	

#Text=The scalp is well healed .
56-1	3345-3348	The	object[216]	new[216]	nonsal[216]	_	_	_	
56-2	3349-3354	scalp	object[216]	new[216]	nonsal[216]	_	_	_	
56-3	3355-3357	is	_	_	_	_	_	_	
56-4	3358-3362	well	_	_	_	_	_	_	
56-5	3363-3369	healed	_	_	_	_	_	_	
56-6	3370-3371	.	_	_	_	_	_	_	

#Text=He still has an open wound on the right posterior aspect of his trunk .
57-1	3372-3374	He	person[217]	giv[217]	nonsal[217]	_	coref	57-13[221_217]	
57-2	3375-3380	still	_	_	_	_	_	_	
57-3	3381-3384	has	_	_	_	_	_	_	
57-4	3385-3387	an	object[218]	new[218]	nonsal[218]	_	coref	58-1[222_218]	
57-5	3388-3392	open	object[218]	new[218]	nonsal[218]	_	_	_	
57-6	3393-3398	wound	object[218]	new[218]	nonsal[218]	_	_	_	
57-7	3399-3401	on	object[218]	new[218]	nonsal[218]	_	_	_	
57-8	3402-3405	the	object[218]|object[219]	new[218]|new[219]	nonsal[218]|nonsal[219]	_	_	_	
57-9	3406-3411	right	object[218]|object[219]	new[218]|new[219]	nonsal[218]|nonsal[219]	_	_	_	
57-10	3412-3421	posterior	object[218]|object[219]	new[218]|new[219]	nonsal[218]|nonsal[219]	_	_	_	
57-11	3422-3428	aspect	object[218]|object[219]	new[218]|new[219]	nonsal[218]|nonsal[219]	_	_	_	
57-12	3429-3431	of	object[218]|object[219]	new[218]|new[219]	nonsal[218]|nonsal[219]	_	_	_	
57-13	3432-3435	his	object[218]|object[219]|object[220]|person[221]	new[218]|new[219]|new[220]|giv[221]	nonsal[218]|nonsal[219]|nonsal[220]|nonsal[221]	_	coref	60-7[231_221]	
57-14	3436-3441	trunk	object[218]|object[219]|object[220]	new[218]|new[219]|new[220]	nonsal[218]|nonsal[219]|nonsal[220]	_	_	_	
57-15	3442-3443	.	_	_	_	_	_	_	

#Text=This has no active drainage , but it is yet to heal .
58-1	3444-3448	This	object[222]	giv[222]	nonsal[222]	_	coref	58-8[224_222]	
58-2	3449-3452	has	_	_	_	_	_	_	
58-3	3453-3455	no	_	_	_	_	_	_	
58-4	3456-3462	active	abstract[223]	new[223]	nonsal[223]	_	_	_	
58-5	3463-3471	drainage	abstract[223]	new[223]	nonsal[223]	_	_	_	
58-6	3472-3473	,	_	_	_	_	_	_	
58-7	3474-3477	but	_	_	_	_	_	_	
58-8	3478-3480	it	object[224]	giv[224]	nonsal[224]	_	coref	59-1[225_224]	
58-9	3481-3483	is	_	_	_	_	_	_	
58-10	3484-3487	yet	_	_	_	_	_	_	
58-11	3488-3490	to	_	_	_	_	_	_	
58-12	3491-3495	heal	_	_	_	_	_	_	
58-13	3496-3497	.	_	_	_	_	_	_	

#Text=This probably will heal by secondary intention once chemotherapy is finished .
59-1	3498-3502	This	object[225]	giv[225]	nonsal[225]	_	_	_	
59-2	3503-3511	probably	_	_	_	_	_	_	
59-3	3512-3516	will	_	_	_	_	_	_	
59-4	3517-3521	heal	_	_	_	_	_	_	
59-5	3522-3524	by	_	_	_	_	_	_	
59-6	3525-3534	secondary	abstract[226]	new[226]	nonsal[226]	_	_	_	
59-7	3535-3544	intention	abstract[226]	new[226]	nonsal[226]	_	_	_	
59-8	3545-3549	once	_	_	_	_	_	_	
59-9	3550-3562	chemotherapy	event[227]	giv[227]	nonsal[227]	_	coref	60-7[230_227]	
59-10	3563-3565	is	_	_	_	_	_	_	
59-11	3566-3574	finished	_	_	_	_	_	_	
59-12	3575-3576	.	_	_	_	_	_	_	

#Text=Prescription for prednisone as part of his chemotherapy has been given to him .
60-1	3577-3589	Prescription	substance[228]	new[228]	nonsal[228]	_	_	_	
60-2	3590-3593	for	substance[228]	new[228]	nonsal[228]	_	_	_	
60-3	3594-3604	prednisone	substance[228]|substance[229]	new[228]|new[229]	nonsal[228]|nonsal[229]	_	_	_	
60-4	3605-3607	as	substance[228]	new[228]	nonsal[228]	_	_	_	
60-5	3608-3612	part	substance[228]	new[228]	nonsal[228]	_	_	_	
60-6	3613-3615	of	substance[228]	new[228]	nonsal[228]	_	_	_	
60-7	3616-3619	his	substance[228]|event[230]|person[231]	new[228]|giv[230]|giv[231]	nonsal[228]|nonsal[230]|nonsal[231]	_	coref	60-13[232_231]	
60-8	3620-3632	chemotherapy	substance[228]|event[230]	new[228]|giv[230]	nonsal[228]|nonsal[230]	_	_	_	
60-9	3633-3636	has	_	_	_	_	_	_	
60-10	3637-3641	been	_	_	_	_	_	_	
60-11	3642-3647	given	_	_	_	_	_	_	
60-12	3648-3650	to	_	_	_	_	_	_	
60-13	3651-3654	him	person[232]	giv[232]	nonsal[232]	_	_	_	
60-14	3655-3656	.	_	_	_	_	_	_	
